Accessibility Menu
NIOX Group Plc logo

NIOX Group Plc(LSE) NIOX

Market Cap£286.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-76%
5 Year+73%
1 Year-8%
1 Month+10%
£0.68
-0.59%
-0.00Today
NIOX Group Plc last closing stock price
MetricPriceDate
Last closeGBX 67.402026-09-02
NIOX Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.75%GBX 68.602026-08-26
1 month+10.49%GBX 61.002026-08-03
3 month+10.13%GBX 61.202026-06-04
Year to date+1.51%GBX 66.402025-12-31
1 year-7.67%GBX 73.002025-09-02
3 year-1.75%GBX 68.602023-09-01
5 year+72.82%GBX 39.002021-09-03
Since inception-75.89%GBX 2.822014-03-13

NIOX Group Plc Financials at a Glance

Market Cap

£286.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£90.50M

Net Income (TTM)

£10.70M

EPS (TTM)

£0.02

P/E Ratio

40.00

Dividend

£0.02

Beta (Volatility)

0.01 (Low)

Price

£0.68

Volume

310,563

Open

£0.68

Previous Close

£0.68

Daily Range

£0.66 - £0.68

52-Week Range

£0.54 - £0.76

Estimated Earnings Date

Sep 29, 2026

NIOX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NIOX Group Plc

NIOX Group Plc is a global leader in the innovation, development, and distribution of medical devices that measure fractional exhaled nitric oxide (FeNO). The company specializes in non-invasive diagnostic tools, with its flagship product being the NIOX VERO system, designed for immediate patient use.

Products and Services
  • NIOX VERO system for measuring FeNO levels
  • Disposable items including sensors and mouthpieces
  • Comprehensive support and training for healthcare professionals
Growth Outlook
  • Revenue increased to £25.2 million in Q2 2025, up from £23.5 million in Q4 2025
  • Net income reached £5.3 million in Q4 2025, showcasing profitability
  • Strong cash flow generation with £8.8 million from operating activities in Q4 2025
Financial Highlights
  • Trailing twelve-month revenue of £90 million, reflecting consistent growth
  • Net profit margin of 14.37% indicates strong operational efficiency
  • Current ratio of 3.81 suggests robust liquidity position
NIOX Group Plc has established itself as a key player in the medical devices sector, particularly in respiratory diagnostics. The NIOX VERO system is pivotal for healthcare providers, enabling quick and accurate assessments of airway inflammation. The company's recent financial performance demonstrates a solid upward trajectory, with significant revenue growth and profitability. The increase in net income and strong cash flow from operations further underscores the company's operational efficiency and financial health. With a strong liquidity position, NIOX Group is well-positioned to capitalize on future growth opportunities in the healthcare market.
AI Generated • Aug 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

97

CEO

Jonathan Emms

Website

www.circassia.co.uk

Headquarters

Oxford, OX OX4 4GA, GB

NIOX Financials

Key Financial Metrics (TTM)

Gross Margin

60.78%

Operating Margin

21.97%

Net Income Margin

14.37%

Return on Equity

10.14%

Return on Capital

14.32%

Return on Assets

9.19%

Earnings Yield

2.50%

Dividend Yield

2.28%

Payout Ratio

71.43%

Stock Overview

Market Cap

£286.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

420.87M

Volume

310.56K

Avg. Volume

744.22K

Financials (TTM)

Gross Profit

£57.70M

Operating Income

£18.40M

EBITDA

£27.00M

Operating Cash Flow

£33.40M

Capital Expenditure

-£200.00K

Free Cash Flow

£33.20M

Cash & ST Invst.

£19.90M

Total Debt

£1.00M

NIOX Group Plc Performance Analysis

NIOX Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 31,300,00012.2%
20232023-12-31GBP 36,800,00017.6%
20242024-12-31GBP 41,800,00013.6%
20252025-12-31GBP 48,700,00016.5%
NIOX Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-2916.7%
Q42024-12-31-1.0%
Q22025-06-3021.2%
Q42025-12-31-6.7%
NIOX Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.04337.3%
20232023-12-31GBP 0.02-34.4%
20242024-12-31GBP 0.01-65.1%
20252025-12-31GBP 0.0297.6%
NIOX Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-29-34.0%
Q42024-12-31-118.6%
Q22025-06-30872.2%
Q42025-12-31-81.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£23.50M

+30.6%

Gross Profit

£14.00M

+9.4%

Gross Margin

59.57%

N/A

Market Cap

£286.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£2.95M

N/A

Employees

97

N/A

Net Income

£1.10M

-83.3%

EBITDA

£6.90M

+102.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£19.90M

+0.0%

Total Debt

£1.00M

-9.1%

Accounts Receivable

£6.00M

-31.8%

Inventory

£5.00M

+4.2%

Long Term Debt

£500.00K

+0.0%

Short Term Debt

£500.00K

-16.7%

Return on Assets

9.19%

N/A

Return on Invested Capital

15.71%

N/A

Free Cash Flow

£8.60M

+30.3%

Operating Cash Flow

£8.80M

+33.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PRTC.LPureTech Health plc
£1.20+0.00%
BXP.LBeximco Pharmaceuticals Limited
£0.63+13.64%
OPT.LOptima Health plc
£2.44+0.00%
AVCT.LAvacta Group Plc
£0.67-1.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$224.41+0.03%
PCGPG&E
$13.33-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.37+0.00%
NUNu Holdings
$15.40+0.07%

Questions About NIOX

What is the current price of NIOX Group Plc?

NIOX Group Plc is trading at £0.68 per share.

What is the 52-week range for NIOX Group Plc?

Over the past 52 weeks, NIOX Group Plc has traded between £0.54 and £0.76.

How much debt does NIOX Group Plc have?

As of the most recent reporting period, NIOX Group Plc reported total debt of £1.00M.

How much cash does NIOX Group Plc have on hand?

NIOX Group Plc reported £19.90M in cash and cash equivalents in its most recent financial results.

What is NIOX Group Plc’s dividend yield?

NIOX Group Plc currently has a dividend yield of 2.28%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services